Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2014 May 20;32(15):1571-7.
doi: 10.1200/JCO.2013.53.2630. Epub 2014 Apr 14.

Doxepin rinse versus placebo in the treatment of acute oral mucositis pain in patients receiving head and neck radiotherapy with or without chemotherapy: a phase III, randomized, double-blind trial (NCCTG-N09C6 [Alliance])

James L Leenstra  1 , Robert C Miller  2 , Rui Qin  1 , James A Martenson  1 , Kenneth J Dornfeld  1 , James D Bearden  1 , Dev R Puri  1 , Philip J Stella  1 , Miroslaw A Mazurczak  1 , Marie D Klish  1 , Paul J Novotny  1 , Robert L Foote  1 , Charles L Loprinzi  1
Affiliations
Clinical Trial

Doxepin rinse versus placebo in the treatment of acute oral mucositis pain in patients receiving head and neck radiotherapy with or without chemotherapy: a phase III, randomized, double-blind trial (NCCTG-N09C6 [Alliance])

James L Leenstra et al. J Clin Oncol. .

Abstract

Purpose: Painful oral mucositis (OM) is a significant toxicity during radiotherapy for head and neck cancers. The aim of this randomized, double-blind, placebo-controlled trial was to test the efficacy of doxepin hydrochloride in the reduction of radiotherapy-induced OM pain.

Patients and methods: In all, 155 patients were randomly allocated to a doxepin oral rinse or a placebo for the treatment of radiotherapy-related OM pain. Patients received a single dose of doxepin or placebo on day 1 and then crossed over to receive the opposite agent on a subsequent day. Pain questionnaires were administered at baseline and at 5, 15, 30, 60, 120, and 240 minutes. Patients were then given the option to continue doxepin. The primary end point was pain reduction as measured by the area under the curve (AUC) of the pain scale using data from day 1.

Results: Primary end point analysis revealed that the AUC for mouth and throat pain reduction was greater for doxepin (-9.1) than for placebo (-4.7; P < .001). Crossover analysis of patients completing both phases confirmed that patients experienced greater mouth and throat pain reduction with doxepin (intrapatient changes of 4.1 for doxepin-placebo arm and -2.8 for placebo-doxepin arm; P < .001). Doxepin was associated with more stinging or burning, unpleasant taste, and greater drowsiness than the placebo rinse. More patients receiving doxepin expressed a desire to continue treatment than did patients with placebo after completion of each of the randomized phases of the study.

Conclusion: A doxepin rinse diminishes OM pain. Further studies are warranted to determine its role in the management of OM.

Trial registration: ClinicalTrials.gov NCT01156142.

PubMed Disclaimer

Conflict of interest statement

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

Figures

Fig 1.
Fig 1.
CONSORT diagram.
Fig 2.
Fig 2.
Crossover analysis of area under the curve (AUC) mouth and throat pain score, phases 1 and 2.
Fig 3.
Fig 3.
Average mouth and throat pain score over time, doxepin versus placebo, phase 1.
Fig A1.
Fig A1.
Mean pain scores over time by arm and sex.
Fig A2.
Fig A2.
Mean pain scores over time by arm and chemotherapy.
Fig A3.
Fig A3.
Mean stinging and burning scores over time.
See this image and copyright information in PMC

References

    1. Lalla RV, Sonis ST, Peterson DE. Management of oral mucositis in patients who have cancer. Dent Clin North Am. 2008;52:61–77. - PMC - PubMed
    1. Saadeh CE. Chemotherapy- and radiotherapy-induced oral mucositis: Review of preventive strategies and treatment. Pharmacotherapy. 2005;25:540–554. - PubMed
    1. Wong PC, Dodd MJ, Miaskowski C, et al. Mucositis pain induced by radiation therapy: Prevalence, severity, and use of self-care behaviors. J Pain Symptom Manage. 2006;32:27–37. - PubMed
    1. Elting LS, Cooksley CD, Chambers MS, et al. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys. 2007;68:1110–1120. - PubMed
    1. Trotti A, Bellm LA, Epstein JB, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review. Radiother Oncol. 2003;66:253–262. - PubMed

Publication types

MeSH terms

Associated data